STOCKWATCH
·
Pharmaceuticals
Acquisitions14 Nov 2025, 05:21 pm

Caplin Point Laboratories Subsidiary Acquires Land in Mexico for Manufacturing Facility

AI Summary

Caplin Point Laboratories Ltd announced that its step-down subsidiary, M/s. Triwin Pharma S.A DE C.V, Mexico, has acquired land measuring approximately 5.5 acres in the Municipality of Capulhuac, District of Tenango Del Valle, State of Mexico. The land was acquired for setting up a manufacturing facility, with an initial capacity expected to be 50 million units per annum. The investment required for the land is USD 22,37,000 (INR 19.85 Crores) and up to USD 15 million (INR 133 Crores) for setting up the manufacturing facility. The rationale behind this move is to enable the company's expansion in the Mexican market and to leverage the incentives in setting up local manufacturing in Mexico.

Key Highlights

  • Caplin Point Laboratories' subsidiary acquires land in Mexico for manufacturing facility
  • Land measures approximately 5.5 acres in the Municipality of Capulhuac
  • Initial capacity expected to be 50 million units per annum
  • Investment required: USD 22,37,000 for land and up to USD 15 million for setting up the facility
  • Move aims to expand company's presence in Mexican market and leverage local manufacturing incentives
CAPPL
Pharmaceuticals
CAPLIN POINT LABORATORIES LTD.

Price Impact